<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>ACKNOWLEDGMENTS</title>
 <p>NVM is supported by Jeanne Timmins Costello, Fonds de Recherche du Québéc-Santé and Parkinson Canada fellowships. FL is supported by a Parkinson Canada fellowship. EF is supported by a Foundation Grant from the Canadian Institutes of Health Research, the Consortium Québécois sur la Découverte du Médicament, Fonds de Recherche du Québéc-Santé Quebec Parkinson Network and the Michael J.Fox Foundation. TMD is supported by a Parkinson’s Canada New Investigator Award, the Consortium Québécois sur la Découverte du Médicament, the Michael J. Fox Foundation and through funding of the brain organoid program at the MNI by the Van Berkom-Saucier Foundation.</p>
</ack>
